These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26027563)

  • 21. Use of Adrenocorticotropic Hormone in Ophthalmology.
    Crane AB; Sharon Y; Chu DS
    J Ocul Pharmacol Ther; 2020 Nov; 36(9):661-667. PubMed ID: 32762596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The need for pharmacovigilance in ophthalmic practice.
    Natarajan S
    Indian J Ophthalmol; 2016 Mar; 64(3):175-6. PubMed ID: 27146926
    [No Abstract]   [Full Text] [Related]  

  • 23. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
    Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
    Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanotechnology in ophthalmology.
    Zarbin MA; Montemagno C; Leary JF; Ritch R
    Can J Ophthalmol; 2010 Oct; 45(5):457-76. PubMed ID: 20871642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ophthalmic Drug Discovery and Development: Regulatory Aspects of Patient Focused Drug Development in Ophthalmology.
    Rowe-Rendleman CL
    Pharm Res; 2019 Feb; 36(4):54. PubMed ID: 30790065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Easy ophthalmic pathology].
    Okisaka S
    Nippon Ganka Gakkai Zasshi; 2005 Jun; 109(6):317-20. PubMed ID: 16116705
    [No Abstract]   [Full Text] [Related]  

  • 27. Advances in nanotechnology for diagnosis and treatment of tuberculosis.
    Banyal S; Malik P; Tuli HS; Mukherjee TK
    Curr Opin Pulm Med; 2013 May; 19(3):289-97. PubMed ID: 23429097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generic medications in ophthalmology.
    Zore M; Harris A; Tobe LA; Siesky B; Januleviciene I; Behzadi J; Amireskandari A; Egan P; Garff K; Wirostko B
    Br J Ophthalmol; 2013 Mar; 97(3):253-7. PubMed ID: 23143788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications.
    Kalomiraki M; Thermos K; Chaniotakis NA
    Int J Nanomedicine; 2016; 11():1-12. PubMed ID: 26730187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dendrimers as a promising tool in ocular therapeutics: Latest advances and perspectives.
    Rodríguez Villanueva J; Navarro MG; Rodríguez Villanueva L
    Int J Pharm; 2016 Sep; 511(1):359-366. PubMed ID: 27436708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanotechnology in ocular delivery: current and future directions.
    Sultana Y; Maurya DP; Iqbal Z; Aqil M
    Drugs Today (Barc); 2011 Jun; 47(6):441-55. PubMed ID: 21695286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroimaging in neuro-ophthalmology.
    Costello FE; Goyal M
    Neurol Clin; 2010 Aug; 28(3):757-87. PubMed ID: 20637999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (Phospho)lipid-based Nanosystems for Skin Administration.
    Vanić Z; Holæter AM; Skalko-Basnet N
    Curr Pharm Des; 2015; 21(29):4174-92. PubMed ID: 26323431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paradigm Shifts in Ophthalmic Diagnostics.
    Sebag J; Sadun AA; Pierce EA
    Trans Am Ophthalmol Soc; 2016 Aug; 114():WP1. PubMed ID: 28008209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of nanotechnology in control of human diseases: perspectives in ocular surface diseases.
    Rai M; Ingle AP; Gaikwad S; Padovani FH; Alves M
    Crit Rev Biotechnol; 2016 Oct; 36(5):777-87. PubMed ID: 26189355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Optovue iVue OCT System from Grafton Optical: the possibilities of hand-held OCT devices in ophthalmic practice.
    Maloney R
    J Vis Commun Med; 2012 Jun; 35(2):76-81. PubMed ID: 22747268
    [No Abstract]   [Full Text] [Related]  

  • 37. Ophthalmic manifestations of endocrine disorders: approaches and medical management.
    Hendrick AM; Kahook MY; Daoud YJ; Hazin R
    Curr Opin Ophthalmol; 2009 Nov; 20(6):495-503. PubMed ID: 19752729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
    Fangueiro JF; Veiga F; Silva AM; Souto EB
    Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular drug delivery: nanomedicine applications.
    Vandervoort J; Ludwig A
    Nanomedicine (Lond); 2007 Feb; 2(1):11-21. PubMed ID: 17716187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceutical microscale and nanoscale approaches for efficient treatment of ocular diseases.
    Bravo-Osuna I; Andrés-Guerrero V; Pastoriza Abal P; Molina-Martínez IT; Herrero-Vanrell R
    Drug Deliv Transl Res; 2016 Dec; 6(6):686-707. PubMed ID: 27766598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.